PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27586473-9	2020	bFGF promoted CAFs proliferation (P &lt;0.01) and migration (P &lt;0.01), protected CAFs from apoptosis (P &lt;0.05) and reduced G0 phase to 49.06% (P &lt;0.01).	cafs	14-18	fibroblast growth factor 2	Homo sapiens	0-4	
27586473-9	2020	bFGF promoted CAFs proliferation (P &lt;0.01) and migration (P &lt;0.01), protected CAFs from apoptosis (P &lt;0.05) and reduced G0 phase to 49.06% (P &lt;0.01).	cafs	84-88	fibroblast growth factor 2	Homo sapiens	0-4	
27586473-10	2020	However, these effects of bFGF on CAFs could be abrogated by PVP.	cafs	34-38	fibroblast growth factor 2	Homo sapiens	26-30	
27586473-12	2020	Moreover, PVP reduced the mRNA expression (P &lt;0.01) and protein secretion of bFGF (P &lt;0.01) in CAFs.	cafs	101-105	fibroblast growth factor 2	Homo sapiens	80-84	
27586473-13	2020	CONCLUSION: PVP could exert an anti-cancer effect on breast CAFs by inhibiting bFGF expression, thus inhibiting the growth of breast cancer SKBr-3 cells indirectly.	cafs	60-64	fibroblast growth factor 2	Homo sapiens	79-83